Clinical outcomes and histological findings of patients with advanced metastatic germ cell tumors undergoing post‐chemotherapy resection of retroperitoneal lymph nodes and residual extraretroperitoneal masses

Abstract

The presence of viable cancer at the retroperitoneal lymph node is an independent predictor of disease recurrence. In approximately one-third of cases, there is a histological discordance between retroperitoneal lymph node and extraretroperitoneal mass. Resection of residual retroperitoneal lymph node and extraretroperitoneal masses remains an important procedure in the management of advanced germ cell tumors.